Measuring Choroidal Thickness Using Optical Coherence Tomography
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-95
SponsorAssiut University
About this trial
To compare the choroidal thickness in eyes of diabetic patients with eyes of age matched controls using optical coherence tomography.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All known Type 2 DM patients aged 30 to 95 years either gender who presented to ophthalmology clinics in Assuit ophthalmology hospital with no history of ocular treatment (ocular treatment naïve) and visual acuity of 0.1 (6/60) or more that are able to complete an eye examination, and non-diabetic healthy individuals (HbA1c <7) will be included in the study.
Disqualifiers
Known diagnosis of any other retinal disease, glaucoma, neurodegenerative disease, and any significant media opacities that precluded fundus imaging and not giving consent will be excluded.
Trial population
known Type 2 DM patients aged 30 to 95 years either gender with no history of ocular treatment and non-diabetic healthy individuals who come to the hosoital
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
optical coherence tomography
Devicemeasuring choroidal thickness using optical coherence tomography
Treatment groups
122 Participants
are divided into 2 treatment groupsGroup A: diabetics1 intervention
Group B: non diabetics1 intervention
Trial outcomes
Primary outcomes
1
comparison between choroidal thickness
To compare choroidal thickness using optical coherence tomography between eyes of healthy individuals and diabetic patients without retinopathy
Time frame
2 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: